Yesterday, at the Medicines for Europe Executive Meeting in Brussels, we tackled key challenges, from strengthening resilient supply chains to fostering a strong off-patent sector—always with #patient access at the core.
We had the opportunity to welcome European Commissioner for Health & Animal Welfare, Olivér Várhelyi, to discuss how the#CriticalMedicinesAct can enhance supply security and ensure #equitable access to #essential medicines across #Europe.
Medichem, represented by Elisabeth Stampa, our Board Member & VP of Medicines for Europe, actively contributed to these discussions.
As we head into 2025, ensuring#sustainable patient #access remains a top priority.
